Wang Huaxin, Cui Yazhou, Luan Jing, Zhou Xiaoyan, Li Chengzhi, Li Haiying, Shi Liang, Han Jinxiang
Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Shandong Medical Biotechnological Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Shandong Academy of Medical Sciences, Jinan, China.
J Bone Miner Metab. 2017 Nov;35(6):608-615. doi: 10.1007/s00774-016-0799-y. Epub 2016 Nov 21.
MicroRNAs have emerged as pivotal regulators in various physiological and pathological processes, including osteogenesis. Here we discuss the contribution of miR-5100 to osteoblast differentiation and mineralization. We found that miR-5100 was upregulated during osteoblast differentiation in ST2 and MC3T3-E1 cells. Next, we verified that miR-5100 can promote osteogenic differentiation with gain-of-function and loss-of-function experiments. Target prediction analysis and experimental validation demonstrated that Tob2, which acts as a negative regulator of osteogenesis, was negatively regulated by miR-5100. Furthermore, we confirmed that the important bone-related transcription factor osterix, which can be degraded by binding to Tob2, was influenced by miR-5100 during osteoblast differentiation. Collectively, our results revealed a new molecular mechanism that fine-tunes osteoblast differentiation through miR-5100/Tob2/osterix networks.
微小RNA已成为包括骨生成在内的各种生理和病理过程中的关键调节因子。在此,我们讨论miR-5100对成骨细胞分化和矿化的作用。我们发现,在ST2和MC3T3-E1细胞的成骨细胞分化过程中,miR-5100表达上调。接下来,我们通过功能获得和功能丧失实验验证了miR-5100可以促进成骨分化。靶标预测分析和实验验证表明,作为骨生成负调节因子的Tob2受到miR-5100的负调控。此外,我们证实,重要的骨相关转录因子osterix可通过与Tob2结合而降解,在成骨细胞分化过程中受到miR-5100的影响。总体而言,我们的结果揭示了一种新的分子机制,即通过miR-5100/Tob2/osterix网络对成骨细胞分化进行微调。